October 5, 2022 — CinCor Pharma, Inc. (NASDAQ: CINC) today announced that the company will present Phase 2 data from ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
October 5, 2022 — University Hospitals (UH) Harrington Heart & Vascular Institute has a rich history of providing the ...
October 5, 2022 — New data presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022, held ...
October 4, 2022 — Newswise — Daxor Corporation, a global leader in blood volume measurement technology, today announces ...
October 4, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase 3out ...
October 4, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heart care, announced that the results of the ...
October 4, 2022 — The American Heart Association (AHA) Scientific Sessions 2022 is set for November 5-7 at McCormick ...
The 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research ...
Here is a recap of what DAIC viewers found most interesting during the month of September:
1. Unloading with Impella ...
October 3, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products ...
October 3, 2022 — Mawi, creators of AI-powered wearable medical devices for cardiac disease diagnostic and monitoring ...
October 3, 2022 — A new ‘ECHO lab’ at Memorial Hospital West is benefiting patients that may have heart disease and the ...
The Photo Gallery includes images taken by DAIC's editorial team at the 34th Transcatheter Cardiovascular Therapeutics ( ...
September 29, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG ...
September 29, 2022 — Bloodstream levels of a protein fragment called endotrophin can be used to predict outcomes in ...
October 05, 2022